Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Ep. 62: Joe Fahmy: Why Biotech Stocks Are Emerging As Leaders In Stock Market Recovery

Ep. 62: Joe Fahmy: Why Biotech Stocks Are Emerging As Leaders In Stock Market Recovery

FromInvesting With IBD


Ep. 62: Joe Fahmy: Why Biotech Stocks Are Emerging As Leaders In Stock Market Recovery

FromInvesting With IBD

ratings:
Length:
48 minutes
Released:
May 21, 2020
Format:
Podcast episode

Description

Joe Fahmy of Zor Capital joined the podcast this week to discuss why the Nasdaq is closing in on all-time highs when the overall economy is struggling. He also talked about why more biotech stocks are coming up on his radar and how investors can comfortably invest in the biotech sector. Plus, we take a look at three potential stocks: Amazon (AMZN), Nvidia (NVDA) and Alteryx (AYX). For the video version, show notes and charts, visit investors.com/podcast.
Released:
May 21, 2020
Format:
Podcast episode

Titles in the series (100)

Welcome to Investing With IBD, a weekly podcast for investors who want to sharpen their trading skills, learn how to make more money and take control over their investment success. From insights into stock market trends, timeless investing tips and fundamental and technical analysis of top stocks using stock charts, this is where you’ll find the expert guidance you need to maximize your gains and minimize your losses. New episode every Thursday.